anagrelide
3 abstracts
Abstract
Phase 3 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with essential thrombocythemia (ET).Org: Sheba Medical Center–Tel HaShomer, Tel Aviv-Yafo, Royal Adelaide Hospital and SA Pathology,
Abstract
EXCEED-ET: A single-arm multicenter study to assess the efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft (P1101) in North American adults with essential thrombocythemia.Org: MD Anderson Cancer Center, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, PharmaEssentia, Rutgers University, PharmaEssentia Japan KK,
Abstract
Expression of CD47 and CALR in myeloproliferative neoplasms: Potential new therapeutical targets.Org: University of Lincoln,